Breaking News - The Fly

Open Search

TYRA

Tyra Biosciences

$

()

Tyra Biosciences price target raised by $4 at H.C. Wainwright, here's why

TYRA

3/20/2024 - 06:08am

Tyra Biosciences files to sell 15.37M shares of common stock for holders

TYRA

3/19/2024 - 16:39pm

Tyra Biosciences reports Q4 EPS (53c), consensus (48c)

TYRA

3/19/2024 - 16:06pm

Tyra Biosciences announces $200M private placement

TYRA

2/2/2024 - 08:07am

Tyra Biosciences receives FDA Rare Pediatric Disease Designation for TYRA-300

TYRA

2/1/2024 - 17:32pm

Wedbush stays Outperform on Tyra Biosciences after pipeline updates

TYRA

12/29/2023 - 07:30am

Tyra Biosciences doses first patient with TYRA-200

TYRA

12/22/2023 - 09:04am

Tyra Biosciences downgraded to Neutral from Buy at BofA

TYRA , BBIO

12/15/2023 - 08:25am

Tyra Biosciences price target lowered to $19 from $20 at H.C. Wainwright

TYRA

11/8/2023 - 06:17am

Tyra Biosciences reports Q3 EPS (49c), consensus (35c)

TYRA

11/7/2023 - 16:23pm

Tyra Biosciences price target raised to $20 from $17 at H.C. Wainwright

TYRA

8/11/2023 - 06:26am

Tyra Biosciences reports Q2 EPS (31c), consensus (34c)

TYRA

8/10/2023 - 16:08pm

Tyra Biosciences announces FDA Orphan Drug Designation for TYRA-300

TYRA

8/1/2023 - 08:02am

Tyra Biosciences granted orphan status for achondroplasia treatment

TYRA

7/31/2023 - 12:29pm

Wedbush starts Tyra Biosciences at Outperform, positive on pipeline potential

TYRA

6/29/2023 - 16:21pm